Intellectual Property India Publishes Patent Application for 'Lymphocyte-Activating Gene 3 (LAG-3) Targeted T Cell Silencer For The Treatment Of Autoimmune Diseases' Filed by New York University

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517045991 A) filed by New York University, New York, on May 13, for 'lymphocyte-activating gene 3 (lag-3) targeted t cell silencer for the treatment of autoimmune diseases.'

Inventor(s) include Wang, Jun; Du, Jasper; and You, Jia.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "Provided are compositions and methods for prophylaxis or therapy of autoimmune disorders. The compositions comprising binding partners configured to locate LAG-3 and a T cell receptor closer to one another than in the absence of the binding partner to thereby provide for an immunosuppressive effect on activated T cells."

The patent application was internationally filed on Oct. 27, 2023, under International application No.PCT/US2023/078092.

Disclaimer: Curated by HT Syndication.